VIRACEPT (nda020778)- (EQ 50MG BASE/SCOOPFUL)

Generic Name	NELFINAVIR MESYLATE	Innovator	AGOURON PHARMS
Dosage	EQ 50MG BASE/SCOOPFUL
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2014-Apr-07	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	VIRACEPT is a protease inhibitor indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 50MG BASE/SCOOPFUL	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of VIRACEPT